C-reactive protein or procalcitonin combined with rhinorrhea for discrimination of viral from bacterial infections in hospitalized adults in non-intensive care units with lower respiratory tract infections

Abstract

Background Whether procalcitonin (PCT) or C-reactive protein (CRP) combined with certain clinical characteristics can better distinguish viral from bacterial infections remains unclear. The aim of the study was to assess the ability of PCT or CRP combined with clinical characteristics to distinguish between viral and bacterial infections in hospitalized non-intensive care unit (ICU) adults with lower respiratory tract infection (LRTI). Methods This was a post-hoc analysis of a randomized clinical trial previously conducted among LRTI patients. The ability of PCT, CRP and PCT or CRP combined with clinical symptoms to discriminate between viral and bacterial infection were assessed by portraying receiver operating characteristic (ROC) curves among patients with only a viral or a typical bacterial infection. Results In total, 209 infected patients (viral 69%, bacterial 31%) were included in the study. When using CRP or PCT to discriminate between viral and bacterial LRTI, the optimal cut-off points were 22 mg/L and 0.18 ng/mL, respectively. When the optimal cut-off for CRP (≤ 22 mg/L) or PCT (≤ 0.18 ng/mL) combined with rhinorrhea was used to discriminate viral from bacterial LRTI, the AUCs were 0.81 (95% CI: 0.75–0.87) and 0.80 (95% CI: 0.74–0.86), which was statistically significantly better than when CRP or PCT used alone (p < 0.001). When CRP ≤ 22 mg/L, PCT ≤ 0.18 ng/mL and rhinorrhea were combined, the AUC was 0.86 (95% CI: 0.80–0.91), which was statistically significantly higher than when CRP (≤ 22 mg/L) or PCT (≤ 0.18 ng/mL) was combined with rhinorrhea (p = 0.011 and p = 0.021). Conclusions Either CRP ≤ 22 mg/L or PCT ≤ 0.18 ng/mL combined with rhinorrhea could help distinguish viral from bacterial infections in hospitalized non-ICU adults with LRTI. When rhinorrhea was combined together, discrimination ability was further improved.

Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review

“… 60 Procalcitonin may represent a promising adjuvant test to CRP but further studies are required to evaluate the clinical and cost efficacy of combined POCT strategies. 61 , 62 …”

Assessment of Serum Procalcitonin Level and Neutrophil /Lymphocyte Ratio in Patients with Lichen Planus

“…On the other hand, circulating endotoxins and cytokines including IL-6, TNF-alpha, and IL-1b may operate on different organs to boost PCT production by a ratio of 100 to 1000. [14].…”

Effects of Methanolic Extract of Aloe vera on C-Reactive Protein and White Blood Cell Count of Wistar Rats With Inflammation

“…Both "pro-inflammatory" and "anti-inflammatory" activities have been described (12). CRP binds to carbohydrates on microorganisms, such as phosphocholine, and activates the classical complement pathway of innate immunity by activation of C1q in the presence of calcium (13). CRP has been reported to play a protective role in a variety of inflammatory disorders, including protecting mice from a deadly challenge with bacterial lipopolysaccharide and other inflammatory mediators (11).…”